Halozyme Acquires Surf Bio in $400 Million Deal to Expand Drug Delivery Capabilities

Leila Ahmed North America Legal Chronicle
Tagged:

Fenwick & West has advised Surf Bio on the deal. Surf Bio, a biopharmaceutical company specializing in innovative drug delivery technologies, has been acquired by Halozyme…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here